Sort:
Open Access Review Issue
Multifunctional metal–organic frameworks as promising nanomaterials for antimicrobial strategies
Burns & Trauma 2025, 13(5): tkaf008
Published: 10 October 2026
Abstract PDF (7.1 MB) Collect
Downloads:1

Bacterial infections pose a serious threat to human health. While antibiotics have been effective in treating bacterial infectious diseases, antibiotic resistance significantly reduces their effectiveness. Therefore, it is crucial to develop new and effective antimicrobial strategies. Metal–organic frameworks (MOFs) have become ideal nanomaterials for various antimicrobial applications due to their crystalline porous structure, tunable size, good mechanical stability, large surface area, and chemical stability. Importantly, the performance of MOFs can be adjusted by changing the synthesis steps and conditions. Pure MOFs can release metal ions to modulate cellular behaviors and kill various microorganisms. Additionally, MOFs can act as carriers for delivering antimicrobial agents in a desired manner. Importantly, the performance of MOFs can be adjusted by changing the synthesis steps and conditions. Furthermore, certain types of MOFs can be combined with traditional photothermal or other physical stimuli to achieve broad-spectrum antimicrobial activity. Recently an increasing number of researchers have conducted many studies on applying various MOFs for diseases caused by bacterial infections. Based on this, we perform this study to report the current status of MOF-based antimicrobial strategy. In addition, we also discussed some challenges that MOFs currently face in biomedical applications, such as biocompatibility and controlled release capabilities. Although these challenges currently limit their widespread use, we believe that with further research and development, new MOFs with higher biocompatibility and targeting capabilities can provide diversified treatment strategies for various diseases caused by bacterial infections.

Open Access Research Article Issue
Human urine-derived stem cells rescue cutaneous manifestation and suppress inflammation and fibrosis in vitro and in a mouse model of recessive dystrophic epidermolysis bullosa
Burns & Trauma 2025, 13(12): tkaf058
Published: 21 August 2025
Abstract PDF (4.3 MB) Collect
Downloads:0
Background

Recessive dystrophic epidermolysis bullosa (RDEB) is a life-threatening disease characterized by persistent wound inflammation, tissue fibrosis, and even tumorigenesis in later stages. Despite its significant impact on patient health worldwide, treatment of RDEB has limited options. There is a clear need for now interventions. The goal of this study was to explore the potential efficacy of urine-derived stem cells (USCs) in RDEB.

Methods

We isolated human USCs from healthy donors, and assessed their therapeutic effects on RDEB both in vitro with tissue-engineered skin in a three-dimensional co-culture system and in vivo with COL7A1−/− (RDEB) mice.

Results

USCs showed suppressive effects on expression of inflammation- and fibrosis-related genes involved in RDEB in vitro and in vivo. USCs could also extend the median life span (from 3 to 5 days), improve the expression of C7, and migrate to various organs of RDEB mice after intrahepatic administration.

Conclusions

In summary, these results suggest the potential effects of USCs on improving the expression of C7 and would repair of RDEB, which supports the future use of USCs for the treatment of RDEB patients.

Review Article Issue
Mesenchymal stem cell-derived exosomes: Versatile nanomaterials for skin wound treatment
Nano Research 2024, 17(4): 2836-2856
Published: 31 August 2023
Abstract PDF (4.2 MB) Collect
Downloads:212

Accumulating studies reveal that mesenchymal stem cells (MSCs) promote skin wound healing mainly through the paracrine effects. Exosomes, one of the crucial paracrine mediators in wound healing, are cell-derived nanosized membranous vesicles containing diverse bioactive cargoes. With the potent ability of modulating skin cell behaviors, MSC-derived exosomes (MSC-Exos) are regarded as a promising nanomaterial for regenerative wound therapy. Under hostile conditions, MSC-Exos are efficient in protecting skin cells from severe damage and restoring their function. According to recent studies, MSC-Exos possess remarkable pro-healing effects in a variety of skin wounds, typically resulting in increased wound closure, inhibited scar tissue formation, and better restoration of skin function. To further enhance the therapeutic potential of MSC-Exos, the development of applicable pretreatment strategies and the optimization of exosome delivery are under intensive investigation. Herein, we summarize current research progress of MSC-Exos for skin wound treatment, with an emphasis on the biological effects of these nanovesicles, the repair mechanisms, and future challenges in clinical translation.

Total 3